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Aquaporin-5 (AQP5), an apical plasma membrane (APM) water channel in salivary glands, lacrimal glands, and airway epithelium, has an
important role in fluid secretion. The activation of M3 muscarinic acetylcholine receptors (mAChRs) or α1-adrenoceptors on the salivary glands
induces salivary fluid secretion. AQP5 localizes in lipid rafts and activation of the M3 mAChRs or α1-adrenoceptors induced its translocation
together with the lipid rafts to the APM in the interlobular ducts of rat parotid glands. This review focuses on the mechanisms of AQP5
translocation together with lipid rafts to the APM in the interlobular duct cells of parotid glands of normal rats and the impairment of AQP5
translocation in diabetes and senescence.
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Rat parotid glands are innervated by both the sympathetic
and parasympathetic nerves of the autonomic nervous system.
Sympathetic stimulation induces the secretion of salivary⁎ Corresponding author. Tel.: +81 88 633 7332; fax: +81 88 633 7332.
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doi:10.1016/j.bbamem.2006.03.026proteins such as amylase and mucin from the secretory granules
in the acinar cells by exocytosis due to activation of β2-
adrenoceptors. Noradrenalin (Nor) released by sympathetic
stimulation also activates α1-adrenoceptors on the cells and
induces modest salivary fluid secretion [1]. Parasympathetic
stimulation induces the largest salivary fluid secretion as a
result of the activation of M3 muscarinic acetylcholine (ACh)
receptors (mAChRs) on the cells [1]. The main component of
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is secreted from the salivary gland cells remain unknown,
because of the presence of the plasma membranes as a major
barrier.
In 1988, a 28-kDa integral membrane protein, now known as
aquaporin-1 (AQP1), was discovered as a water channel [2,3].
There have been many attempts at homology cloning to isolate
water channel proteins and to identify sequence-related
proteins in many kinds of living cells. AQP water channel
proteins are abundant in a variety of cells for the transportation
of fluid and have homology with the major intrinsic proteins of
the lens, which form water channels [4]. Thirteen members of
the AQP family, AQP0–AQP12, have been identified from
many mammalian cells [5,6]. The AQP family consists of three
subsets coresponding to AQPs, aquaglyceroporins, and super-
aquaporins. AQPs selectively permeate water and consist of
AQP0, AQP1, AQP2, AQP4, AQP5, AQP6, and AQP8.
Aquaglyceroporins permeate water and glycerol and consist of
AQP3, AQP7, AQP9, and AQP10 [5]. Superaquaporins have
poorly conserved asparagin–proline–alanine (NPA) boxes and
consist of AQP11 and AQP12 [6].
Recently, studies have focused on the mechanisms underly-
ing the control of AQPs to clarify the molecular basis of water
movement across biologic membranes in relation to disease [4–
13]. Impaired AQP2 trafficking causes nephrogenic diabetes
insipidus [8,9]. Changes in AQP1, AQP4, and AQP9 expression
in the brain are correlated with edema formation [10,11].
Autoantibodies on the mAChRs in Sjogren's syndrome cause to
decrease pilocarpine-induced AQP5 trafficking to APM of HSG
cells [13], suggesting the importance of AQP5 trafficking to the
APM of salivary glands in mACh agonist-induced exocytosis.
The AQP5 cDNA, which encodes a 265-residue polypeptide,
was isolated from rat submandibular gland with the use of a
homology-based cloning approach by Raina et al. [14]. AQP5 is
highly expressed in the apical domains of rat serous acinar cells of
exocrine glands, such as the parotid and submandibular glands
[15–17], lacrimal glands [18], and sweat glands [19], subepithe-
lial glands of the upper airway [20], and rat interlobular duct cells
of parotid glands [16]. AQP5 is predicted to have a significant
role in fluid secretion from serous acinar cells of salivary glands
on the basis of its abundance in the apical region of the cells. This
is supported by the fact that knockout mice lacking AQP5 have
markedly decreased rates of salivary secretion [21].
Activation of M3 mAChRs and α1-adrenoceptors on the
acinar cells of rat parotid glands increase the intracellular
concentration of Ca2+([Ca2+]i) and induces salivary secretion
from the cells [1,22–25], indicating the importance of Ca2+-
mediated intracellular signal transduction for the secretion.
Whether the subcellular distribution of AQP5 is regulated by
Ca2+-signaling through M3 mAChRs and α1-adrenoceptors in
parotid glands, however, was unknown. We studied whether the
stimulation of salivary fluid secretion is accompanied by the
redistribution of AQP5 into the apical plasma membranes
(APM) from the intracellular structures, the regulatory mechan-
isms of the redistribution of AQP5, and the characterization of
the structures where AQP5 is located in the parotid gland cells
[13–17,21,23–26]. We also focused here whether the inductionof salivary fluid secretion is accompanied by the translocation
of AQP5 together with lipid rafts into the APM via intracellular
Ca2+-signaling and dissociation of AQP5 from the lipid rafts at
the APM, and the molecular mechanisms that underlie impaired
responsiveness of AQP5 to neurotransmitters as a consequence
of aging or diabetes-related xerostomia.
2. Distribution of AQP5 in salivary gland cells
AQP5 has been identified with AQP1, AQP3, and AQP8 in
mammalian salivary glands [26]. AQP1 is expressed in the cap-
illary endothelial cells of rat parotid and submandibular glands [27].
AQP8 is also expressed in rat salivary glands [28,29], but the
localization of it is not clear. AQP5 is localized in the APM of
serous acinar cells of rat submandibular [14,20] and parotid [15–
17,21,23–26] glands, and of interlobular duct cells of rat parotid
glands [16]. AQP5 is also localized in the intracellular structures in
rat parotid gland cells [15,16,30,31]. To directly visualize the
subcellular localization of AQP5 in rat parotid glands, a histologic
approach was used [16]. Confocal immunofluorescence micro-
scope images revealed that in the interlobular duct cells of rat
parotid glands under resting conditions, AQP5 is located in the
intracellular structures as well as in the APM (Fig. 1) [16]. To
quantify the subcellular distribution of AQP5, the interlobular duct
cells were analyzed in sections from control rat parotid glands with
immunoelectron microscopy. Immunogold labeling at the APM
and within the intracellular compartment was assessed on sections
from unstimulated parotid glands of different rats. Under resting
conditions, 90% of the immunogold particles were associated with
intracellular compartments, the remaining 10% were associated
with the APM. Thus, under resting conditions, AQP5 was mainly
localized in intracellular vesicular structures in the interlobular duct
cells of rat parotid glands. AQP5 is located in the cytoplasmic
vesicles [30] and the secretory granule membranes [31] of rat
parotid glands. AQP1 is localized in the zymogen granules in rat
exocrine pancreas [32]. AQP6 is located in the intracellular vesicles
in renal epithelia [33]. Thus, different AQP homologues are
localized in different cell membranes and in various intracellular
organelles in many kinds of cells.
3. Association of AQP5 with lipid rafts in rat parotid gland
cells
Under resting conditions, AQP5 is localized in the intra-
cellular structures of rat parotid gland cells (Fig. 1) [15,16]. The
intracellular structures where AQP5 is located in rat parotid
gland cells remain to be characterized. Cholesterol- and glyco-
sphingolipid-enriched microdomains, commonly known as lipid
rafts, were recently suggested to be involved in a number of cell
functions, such as membrane sorting and trafficking [34–39],
receptor signaling [40], and cholesterol homeostasis [41]. For
example, transcytosis of IgA and exocytosis of newly made
brush-border proteins in enterocytes occur through an apical
lipid raft-containing compartment [42]. These findings suggest
that lipid rafts are involved in sorting some apical resident
proteins. In order to characterized the intracellular vesicles in rat
parotid glands where AQP5 is located, flotillin-2 and GM1
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protein and glycosphingolipid, respectively, were used as raft
markers [38] to determine if AQP5 is located in lipid rafts in rat
parotid gland cells. Confocal immunofluorescence microscope
images revealed that under resting conditions, AQP5 was colo-
calized with flotillin-2 and GM1 in the cytoplasm of rat parotid
gland cells, indicating that AQP5 is located in lipid rafts [16].
This result was further supported by sucrose density gradient
experiments in which AQP5 in rat parotid gland tissues, under
unstimulated conditions, fractionated to the same fractions con-
taining flotillin-2 andGM1 [16]. Lipid rafts migrate to the lighter
density fractions in an Opti-Prep discontinuous density gradient
[39,43]. After separation of the rat parotid tissue homogenate on
the Opti-Prep gradient, the amount of AQP5 in the tissues under
resting conditions was highest in the lighter fractions, indicating
that AQP5 is located with lipid rafts in resting parotid gland cells
of rats. Next, to test the solubility of AQP5 in cold detergent, rat
parotid slices were treated with solution containing 1%Triton X-
100 for 30 min at 4 °C [35,39]. The homogenate was then
centrifuged to separate TritonX-100-insoluble and -soluble
fractions. Under resting conditions, the major portion of AQP5
was present in the Triton X-100-insoluble fraction, revealing theFig. 1. Changes in confocal immunofluorescence microscope images of AQP5 and C
with cevimeline. Parotid glands were obtained from rats injected with physiologic sa
were removed and embedded 0 min (A), 10 min (B and E), or 60 min (C and F) after in
A, B, and C) and Alexa-568 (red, D-2, E-2, F-2) or CLC-K2 using Alexa-488 (gree
10 μm.localization of AQP5 in lipid rafts [16]. These results indicated
that AQP5 is located in lipid rafts in the cytoplasm of parotid
gland cells under resting conditions.
4. Translocation of AQP5 together with lipid rafts to the
APM and its dissociation to non-rafts in rat parotid gland
cells
It is well documented that salivary fluid secretion is induced
by the binding of neurotransmitters from autonomic nerve
endings to M3 mAChRs or α1-adrenoceptors localized on the
basolateral plasma membrane of parotid acinar cells [1]. The
responsiveness of AQP5 in salivary gland cells to stimulation
with M3 agonists or α1 agonists was investigated to evaluate the
role of AQP5 in salivary secretion. Treatment of the tissues with
ACh induces AQP5 translocation from the intracellular
structures to the APM within 1 min, but treatment for more
than 5 min results in AQP5 translocation from the APM to the
intracellular structures [15]. SNI-2011, cevimeline, acting at M3
receptors induces a long-lasting increase in the amount of AQP5
in the APM of rat parotid glands [24]. Treatment of rat parotid
tissues with epinephrine also induces transient and markedLC-K2 in interlobular duct cells and acinar cells of parotid glands of rat injected
line (A and D) and cevimeline (5.0 mg/kg) (B, C, E and F). The parotid glands
jection. The section was immunostained to detect AQP5 using Alexa-488 (green,
n, D-1, E-1, and F-1). Nuclei were stained with ethidium bromide. Scale bars:
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APM [23]. Cytochalasin D and tubulozole-C inhibited the
translocation of AQP5 to the APM, suggesting the importance
of the cytoskeleton in this translocation [22,44]. The trafficking
of AQP5 induced by cholinergic or adrenergic stimulation in rat
parotid glands was directly visualized with immunohistochem-
istry [16]. Immunoelectron microscopy of AQP5 expression in
interlobular duct cells of rat parotid gland revealed that 10 min
after the intravenous injection of cevimeline, the percentage of
gold particles in the APM rose to 70% from 10% (under resting
conditions) and that of the remaining gold particles localized
intracellularly fell to 30% from 90% (under resting conditions),
indicating the translocation of AQP5 to the APM in response to
cevimeline treatment. Confocal immunofluorescence microscope
images revealed that cevimeline induced the translocation of the
immunofluorescence of AQP5 together with that of flotillin-2 or
GM1 towards the APM in rat interlobular duct cells 10 min after
intravenous injection into the tail vein (Fig. 1B) [16]. Sixty
minutes after the treatment, immunofluorescence was dispersed
throughout the cell (Fig. 1C). These results indicate that AQP5
translocates with lipid rafts to the APM of interlobular duct cells
of rat parotid glands, suggesting that water is secreted from
interlobular duct cells of rat parotid glands as well as acinar
cells. This suggestion is also supported by several cell lines of
evidence of an important role for the ductal system in fluid
secretion in pancreas [45].
As mentioned above, the major portion of AQP5 was present
in the TritonX-100-insoluble fraction under resting conditions of
rat parotid gland tissues. Conversely, after the treatment with
cevimeline, the amount of AQP5 decreased in the TritonX-100-
insoluble fraction and increased in the TritonX-100-soluble frac-
tion. In contrast, cevimeline did not change the amount of flotillin-
2 and GM1 in the Triton-X-100-insoluble fraction. These results
indicate that M3 mAChR agonists and α1-adrenoceptor agonists
induces the translocation of AQP5 with lipid rafts from the intra-
cellular structures to the APM and the dissociation of AQP5 from
lipid rafts to non-rafts at the APM in rat parotid glands [16],
suggesting that the lipid-AQP5 interactions are important to play
the function of AQP5 on the APM.
5. Water movements and the osmolarity generation in
parotid interlobular ducts
Water moves passively in response to osmotic gradients
generated by active Cl− driven HCO3
− secretion [46]. Salivary
gland express multitype types of Cl− channels including Ca2+-
dependent and volume-sensitive channels [47], the cystic fibrosis
transmembrane conductance regulator (CFTR)[48] and the
voltage-regulated ClC-2 and ClC-3 Cl− channels [49]. CFTR is
located in interlobular ducts of rat parotid glands [48] and
cholangiocytes of rat liver [46]. Secretin and dibutyryl-cAMP
stimulate the translocation of CFTR from intracellular vesicles to
the APM [46]. Recently, we found that CLC-K2 (Cl− channel)
was also expressed in the cytoplasm of interlobular duct cells of
rat parotid glands and colocalized with AQP5 in lipid rafts under
unstimulated conditions (Fig. 1D-1) [61]. Ten minutes after the
injection of cevimeline, CLC-K2 moved to APM together withAQP5 as shown in Fig. 1E-1 and E-2 [61], suggesting that CLC-
K2 play a role to make osmotic gradients. Further experiments
are, however, necessary to clarify the interaction Cl− channel with
the appearance of the function of AQP5 in salivary glands.
In the first stage, saliva is secreted initially from the acinar cells
[50]. This saliva is called primary saliva and is plasma-like in
concentration of Na+, Cl−, and HCO3
−. In the second stage, the
primary saliva is modified in duct cells. It was notified by the old
theory that the ducts seem to be impermeability to water, but Na+
is actively reabsorbed and K+ secreted from the duct cells [50].
However, there are ample evidences for permeability to water in
parotid interlobular ducts. For example, forskolin or carbachol
evokes water secretion from rat parotid interlobular duct, asso-
ciated with secretion through CFTR and diphenylamine-2-
carboxylate-sensitive anion channels of carbonic anhydrase-
dependent bicarbonate linked with the Na+/H+ exchange
mechanism [51,52], suggesting that salivary fluid is secreted
from parotid interlobular duct cells as well as acinar cells.
6. Mechanisms underlying the translocation of AQP5
towards the APM
Salivary fluid secretion is controlled throughM3mAChRs and
α1-adrenoceptors [1]. AQP5 is likely to be a target molecule for
the control of saliva production. The treatment of rat parotid
tissues with ACh, cevimeline, or epinephrine induces the
translocation of AQP5 between the APM and the intracellular
structures [15,16,23,24]. The translocation of AQP5 induced by
M3 mAChR agonists is inhibited by an inhibitor of calcium
release from the intracellular compartment, TMB-8, but not by
protein kinase C (PKC) inhibitors, H-7 and GF 109203X. Con-
versely, a PKC activator, phorbol 12-myristate 13-acetate, does
not induce the translocation of AQP5 [24]. The calcium
ionophore A-23187 induces the translocation of AQP5 between
the APM and the intracellular structures [15,16]. Epinephrine
acting at α1-adrenoceptors in parotid glands also induced the
translocation of AQP5 from the intracellular structures to
the APM [23]. The translocation of AQP5 induced by ACh
or epinephrine is inhibited by a phospholipase C inhibitor,
U73122, as well as the inhibitors of calcium release inhibition
from intracellular stores, dantrolene, and TMB-8 [24]. Fluores-
cence studies with fura-2/AM demonstrate that [Ca2+]i rapidly
increases in a concentration-dependent manner with marked
fluctuations after exposure of the isolated parotid acinar cells to
ACh and cevimeline [24,25], and that the elevation of AQP5
levels in the APM coincided with the elevation of [Ca2+]i. The
presence of extracellular Ca2+ was necessary for the maximum
effect of ACh on the increase of AQP5 in the APM in parotid
tissues [25]. An inhibitor of myosin light chain kinase (MLCK),
ML-9, inhibited ACh- or pilocarpine-induced increases in the
AQP5 levels in the APM [25]. MLCK was identified in parotid
glands and regulates capacitative Ca2+ entry [53]. It is suggested
that both the Ca2+ release from intracellular stores and the entry of
Ca2+ into cells regulate the translocation of AQP5 from the
intracellular structures to the APM in rat parotid glands.
Furthermore, to confirm the involvement of Ca2+ in the trans-
location of AQP5, the Ca2+ ionophore, A-23187, was injected
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jection, AQP5 fluorescence was predominantly associated with
the APM of the interlobular duct cells of parotid glands. Treat-
ment of the parotid tissues with A-23187 decreased the amount of
AQP5 in the TritonX-100-insoluble fraction [16]. These findings
suggest that increases in [Ca2+]i mediate the effects of cevimeline
on themovement ofAQP5with lipid rafts from the cell cytoplasm
to the APM and subsequently the dissociation of AQP5 from lipid
rafts to non-rafts within the APM. The site of action of Ca2+ for
themovement and dissociation of AQP5 in parotid gland cells has
not been clarified. In Ca2+-mediated intracellular signal trans-
duction, an increase in [Ca2+]i has an important role in the
activation of Ca2+/calmodulin (CaM)-dependent proteins, such as
CaM kinase, MLCK, and nitric oxide synthase (NOS). CaM
kinase is a multifunctional enzyme required for both granule
mobilization under stimulation conditions and maintenance of
secretory capacity under resting conditions in pancreatic β-cells
[54]. MLCK regulates capacitative Ca2+ entry [53] and is
involved in the Ca2+-dependent secretion of insulin [55] and
rennin [56]. Nitric oxide (NO) increases cGMP formation through
the stimulation of guanylyl cyclase (GC) [57,58]. The possible
roles of CaM kinase, NOS, MLCK, and protein kinase G (PKG)
in the regulation of the function of AQP5 were investigated to
clarify the molecular basis of water movement across the biologic
membranes in parotid gland cells [25]. Western blot analysis
demonstrated that neuronal (n) NOS is expressed in isolated
parotid acinar cells, but endothelial and inducible NOS are not
[22]. Carboxy-PTIO, an NO scavenger, inhibits ACh- and
pilocarpine-induced increases in AQP5 in the APM in rat parotid
glands. SIN-1 and SNAP, NO donors, mimic the effects of ACh
[25]. KT5823 and L-Nil, inhibitors of PKG and NOS,Fig. 2. Schematic representation of signal transduction in M3 muscarinic receptor-
receptor, α1R; α1 adrenergic receptors, Gq, G protein that stimulates phospholipase C
inositol 1,4,5-trisphosphate. IP3R, IP3 receptor; Ry3R, Ryanodine receptor type 3; Ar
neuronal, nitric-oxide synthase; sGC, soluble guanylate cyclase; PKG, cGMP-depend
basolateral plasma membrane. Gray circle is lipid rafts.respectively, block NO donor-induced increases in AQP5 in the
APM. KN-62, an inhibitor of CaM kinase ∣∣, decreases the
pilocarpine-induced increase in AQP5 in the APM [25]. A study
using diaminofluorescein-2 diacetate demonstrates enhanced
NOS activity in isolated parotid acinar cells in real time after
ACh-treatment. Treatment with dibutyryl cGMP, but not dibu-
tyryl cAMP, induces an increase in AQP5 in the APM. BAPTA-
AM, a cell-permeable Ca2+ chelator prevents the cGMP-induced
increase in AQP5 in the APM. Pretreatment of the parotid tissues
with ML-9, an MLCK inhibitor, inhibited the ACh-induced
increase in AQP5 in the APM. AQP1 has a cyclic nucleotide
binding domain in the C terminus [59]. PKG phosphorylates
AQP2 on the C terminal residue and increases the insertion of
AQP2 into renal epithelial cells [60]. The PKG regulatory me-
chanism on AQP5 proteins in parotid glands, however, remains
unknown. These results are summarized in Fig. 2, suggesting that
NO/cGMP signal transduction has a crucial role in Ca2+ home-
ostasis in the ACh-stimulated increase in AQP5 in the APM of rat
parotid gland.
7. The mechanisms underlying age- and diabetes-related
impairment of the responsiveness of AQP5 to cholinergic
stimulation
The importance of AQPs in human diseases is recently
clarifying [4,5,8–13]. The study of subcellular localization of
AQP5 provides details of the molecular mechanisms for xeros-
tomia. Xerostomia is characterized by oral dryness and dif-
ficulty performing oral functions and in tolerating dentures.
Diabetic patients or aged people often complain of xerostomia,
but the mechanisms have not been clarified.induced the translocation of AQP5 in rat parotid glands. M3R; M3 muscarinic
(PLC); PIP2, phosphatidylinositol 4, 5-bisphosphate; DAG, diacylglycerol; IP3,
g, Arginine; CaM, calmodulin; CaMKII, calmodulin-dependent kinaseII; nNOS,
ent protein kinase; cADPr, cADP-ribose; APM, apical plasma membrane; BLM,
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response to M3 agonists have been studied to clarify the mech-
anisms underlying age-related xerostomia [62]. ACh and epi-
nephrine induce increases in AQP5 levels in the APM of parotid
cells of both young adult and senescent rats. The stimulatory
effect of ACh, but not that of epinephrine, on AQP5 levels in the
APM of the cells decreases markedly during aging. The amounts
of AQP5, M3 mAChRs, inositol trisphosphate (IP3), and Gq/
11α proteins do not decrease during aging. This finding in-
dicates that AQP5 responsiveness to cholinergic, but not
adrenergic, stimulation is markedly decreased in the parotid
cells of senescent rats. The changes in NOS activities measured
in real time using 4,5-diaminofluorescein/diacetate in isolated
parotid acinar cells from young adult and senescent rats treated
with ACh or epinephrine coincides with those of the res-
ponsiveness of AQP5 in these cells. Confocal images revealed
that under unstimulated conditions, AQP5 fluorescence locates
in a diffuse pattern in the cytoplasm of parotid acinar cells of
both young adult and senescent rats. Ten minutes after the
intravenous injection of cevimeline, AQP5 fluorescence does
not localize in the APM of parotid acinar cells of senescent rats,
in contrast with that of young adult rats [56]. These findings
indicate that the age-related impairment of the responsiveness of
AQP5 in parotid cells to muscarinic stimulation might account
for the concomitant changes in NOS activity in the cells, and
might induce age-related xerostomia [62,63].
To study the mechanisms underlying diabetic xerostomia,
changes in the distribution of AQP5 in the interlobular duct cells
of parotid glands were investigated after the administration of
cevimeline into the tail vein of control and streptozotocin-in-
duced diabetic (diabetic) rats [64]. Confocal images revealed
that under unstimulated conditions, AQP5 colocalized with
flotillin-2 and GM1, lipid raft markers, with a diffuse pattern in
the cytoplasm of interlobular duct cells of parotid glands of both
control and diabetic rats. Ten minutes after intravenous injection
of cevimeline, AQP5 levels dramatically increased together with
flotillin-2 and GM1 in the APM of the cells of control rats, and
then AQP5 was again colocalized with flotillin-2 and GM1 in a
diffuse pattern in the cytoplasm 60 min after the injection. The
cevimeline-induced trafficking of AQP5 between the APM and
intracellular structures are not observed in the cells of diabetic
rats. Treatment of the parotid tissues with cevimeline induces a
decrease in the TritonX-100 insolubility of AQP5 in control rats,
but not in diabetic rats. These findings indicate the impairment of
AQP5 trafficking between APM and intracellular structures with
lipid rafts and that of AQP5 dissociation from lipid rafts to non-
rafts on the APM in the interlobular duct cells of diabetic rat
parotid glands. The amount of AQP5 does not decrease in
parotid glands of diabetic rats compared with that of control rats
[64]. In contrast, there is a 50% decrease in M3mAChRs parotid
glands of diabetic rats. Administration of insulin to diabetic rats
recovers the distribution and dissociation of AQP5 as compared
to control rats. Treatment with cevimeline of isolated parotid
acinar cells from diabetic rats loaded with DAF-2/DA did not
induce a fast and significant increase in the fluorescent triazol
formed by DAF-2 and NO in the presence of oxygen as observed
in control rats, demonstrating that cevimeline did not stimulateNOS activity in parotid acinar cells of diabetic rats. Injection of
insulin to diabetic rats showed the same distribution and
dissociation of AQP5 as those observed in normal control rats
[57]. These findings indicate that the decrease in the amount of
Ca2+ released from intracellular Ca2+ stores via IP3 receptors
according to the decrease in the amount of IP3 synthesized
through agonist-induced activation ofM3mAChRs decreased in
parotid glands of diabetic rats. Finally, the impairment of
translocation of AQP5 to the APM in parotid gland cells induced
by the decline in Ca2+ signaling via M3 mAChRs in parotid
glands is important in the mechanisms underlying diabetes-
related xerostomia. These findings support also that water is
secreted from not only acinar cells but also interlobular duct cells
of rat parotid glands.
8. Conclusion
The increases in [Ca2+]i in salivary gland cells by the
activation of M3 mAChRs and α1-adrenoceptors play a crucial
role on salivary fluid secretion. It is documented that water, the
main component of saliva, is secreted with Na+ and K+ into the
duct system from serous acinar cells in salivary glands as the
primary saliva component. Subsequently, water and K+ are also
secreted from the interlobular duct cells in the glands and in
contrast, Na+ is absorbed into the cells as they pass along the
duct. It was also shown that water was secreted from not only the
acinar cells but also the interlobular duct cells of parotid glands
by the translocation of AQP5 water channel together with lipid
rafts to the APM from intracellular vesicles in these cells by Ca2+
signaling through M3 mAChRs or α1 adrenoceptors [16].
Therefore, the principal sites for water transport are both the
acinar cells and interlobular duct cells in the salivary glands.
AQP5 is a target molecule for sympathetic or parasympa-
thetic control of saliva production. As shown in Fig. 2, the
activation of M3 mAChRs and α1-adrenoceptors induced the
interaction of IP3 receptors and ryanodine receptors with IP3 and
cADP ribose, respectively, via sGC/PKG signaling. The increase
in [Ca2+]i released from intracellular storage sites by the
activation of IP3 receptors and ryanodine receptors induced
translocation of AQP5 together with lipid rafts from the
intracellular structures to the APM in the interlobular duct
cells of rat parotid glands. Then, at the APM, AQP5 located with
lipid rafts was dissociated to non-rafts via the increase in [Ca2+]i.
Thus, AQP5 in salivary glands [16] and lung [65] is subjected
to trafficking between the intracellular structures and the APM in
response to neurotransmitters or hormones as well as AQP2 ileal
collecting duct cells [8], AQP1 in rat cholangiocytes [66], and
AQP8 in hepatocytes [67]. At the APM, AQP5 moves between
lipid rafts and non-rafts, suggesting that protein–lipid interaction
is important to play a role of AQP5. It is very interesting that the
impaired responsiveness of AQP5 to M3 mAChRs results in
xerostomia. Furthermore, it is important to study the mechan-
isms that control the polarization of AQPs coupled with fluid
flow and the network of the AQPs involved in fluid secretion
from salivary glands. Recently, in order to search the domain in
AQP5 structures to facilitating to target the APM, much interest
has been focused on N- or C-termini of AQP5 [68]. Further
1059Y. Ishikawa et al. / Biochimica et Biophysica Acta 1758 (2006) 1053–1060experiments are necessary to clarify the mechanisms in the
translocation of AQP5 in relation with those.
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